0001209191-21-017764.txt : 20210304 0001209191-21-017764.hdr.sgml : 20210304 20210304160508 ACCESSION NUMBER: 0001209191-21-017764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210302 FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Grady Brendan P. CENTRAL INDEX KEY: 0001726533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 21714121 MAIL ADDRESS: STREET 1: 5 BASEL STREET, PO BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 FORMER NAME: FORMER CONFORMED NAME: O'Grady Brendan DATE OF NAME CHANGE: 20171227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-02 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001726533 O'Grady Brendan P. C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 EVP, North America Commercial Ordinary Shares 2021-03-02 4 S 0 15085 10.8453 D 14868.486 D Ordinary Shares 2021-03-03 4 M 0 1166 A 16034.486 D Ordinary Shares 2021-03-03 4 S 0 463 10.8626 D 15571.486 D Restricted Share Units 2021-03-03 4 M 0 1166 0.00 D Ordinary Shares 1166 0 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.800 to $10.870, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.835 to $10.910, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Restricted share units were granted on March 3, 2017, with 1,166 vesting on each of March 3, 2018, March 3, 2019, March 3, 2020 and March 3, 2021. /s/ Dov Bergwerk as attorney-in-fact for Brendan P. O'Grady 2021-03-04